ANESTACON Drug Patent Profile
✉ Email this page to a colleague
When do Anestacon patents expire, and what generic alternatives are available?
Anestacon is a drug marketed by Bionpharma and is included in one NDA.
The generic ingredient in ANESTACON is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Anestacon
A generic version of ANESTACON was approved as lidocaine hydrochloride by WOCKHARDT BIO AG on November 18th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ANESTACON?
- What are the global sales for ANESTACON?
- What is Average Wholesale Price for ANESTACON?
Summary for ANESTACON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 131 |
| Patent Applications: | 4,432 |
| DailyMed Link: | ANESTACON at DailyMed |
US Patents and Regulatory Information for ANESTACON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bionpharma | ANESTACON | lidocaine hydrochloride | JELLY;TOPICAL | 080429-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
